Hinge Health (HNGE) president sells 33,000 shares under trading plan

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) reported that President James Pursley sold a total of 33,000 shares of Class A Common Stock on August 21, 2026, in multiple open-market transactions under a Rule 10b5-1 trading plan adopted on June 13, 2025. The reported weighted average sale prices ranged from about $84.80 to $88.68 per share across the four tranches.

Insider Trade Summary 10b5-1

Net Seller: 33,000 shares

Net Sell 4 txns

Insider Pursley James

Role President

Sold 33,000 shs ($2.91M)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2	500	$84.802	$42K
Sale	Class A Common Stock F1, F3	6,300	$87.2316	$550K
Sale	Class A Common Stock F1, F4	22,789	$88.2536	$2.01M
Sale	Class A Common Stock F1, F5	3,411	$88.6813	$302K

Holdings After Transaction: Class A Common Stock — 706,235 shares (Direct)

Footnotes (5)

1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.
2. F2. Represents the weighted average sale price. The lowest price at which shares were sold was $84.65 and the highest price at which shares were sold was $85.03. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
3. F3. Represents the weighted average sale price. The lowest price at which shares were sold was $86.57 and the highest price at which shares were sold was $87.56. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
4. F4. Represents the weighted average sale price. The lowest price at which shares were sold was $87.58 and the highest price at which shares were sold was $88.575. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
5. F5. Represents the weighted average sale price. The lowest price at which shares were sold was $88.58 and the highest price at which shares were sold was $88.94. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Key Figures

Total shares sold: 33,000 shares First tranche: 500 shares at $84.8020 Second tranche: 6,300 shares at $87.2316 +2 more

5 metrics

Total shares sold 33,000 shares Aggregate Class A Common Stock sales on August 21, 2026

First tranche 500 shares at $84.8020 Weighted average sale price for one tranche on August 21, 2026

Second tranche 6,300 shares at $87.2316 Weighted average sale price for one tranche on August 21, 2026

Third tranche 22,789 shares at $88.2536 Weighted average sale price for one tranche on August 21, 2026

Fourth tranche 3,411 shares at $88.6813 Weighted average sale price for one tranche on August 21, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"Represents the weighted average sale price. The lowest price at which shares were sold"

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

FAQ

What insider transaction did HNGE report for President James Pursley?

HNGE reported that President James Pursley sold 33,000 shares of Class A Common Stock on August 21, 2026, in a series of open-market transactions executed under a Rule 10b5-1 trading plan.

At what prices were James Pursley’s HNGE shares sold?

The sales used weighted average prices: $84.8020, $87.2316, $88.2536, and $88.6813 per share, each corresponding to trades executed within disclosed price ranges in the Form 4 footnotes.

How many HNGE shares did James Pursley sell in each transaction?

On August 21, 2026, James Pursley sold 500, 6,300, 22,789, and 3,411 HNGE Class A Common shares in four separate transactions, totaling 33,000 shares sold.

Was James Pursley’s HNGE stock sale under a Rule 10b5-1 plan?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by James Pursley on June 13, 2025, and the Rule 10b5-1 checkbox is affirmed.

Does the Form 4 show James Pursley’s remaining HNGE holdings?

The reported transactions list the shares sold but do not state a specific total for shares beneficially owned after the transactions in the available data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/24/2026 - 05:32 PM Accepted by SEC EDGAR 08/24/2026 - 05:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pursley James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/21/2026		S(1)		500	D	$84.802(2)	738,735	D
Class A Common Stock	08/21/2026		S(1)		6,300	D	$87.2316(3)	732,435	D
Class A Common Stock	08/21/2026		S(1)		22,789	D	$88.2536(4)	709,646	D
Class A Common Stock	08/21/2026		S(1)		3,411	D	$88.6813(5)	706,235	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.

2. Represents the weighted average sale price. The lowest price at which shares were sold was $84.65 and the highest price at which shares were sold was $85.03. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

3. Represents the weighted average sale price. The lowest price at which shares were sold was $86.57 and the highest price at which shares were sold was $87.56. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

4. Represents the weighted average sale price. The lowest price at which shares were sold was $87.58 and the highest price at which shares were sold was $88.575. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

5. Represents the weighted average sale price. The lowest price at which shares were sold was $88.58 and the highest price at which shares were sold was $88.94. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

	/s/ Mahnaz Dodge, Attorney-in-Fact	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)